LGVN
Longeveron Inc. [LGVN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LGVN Stock Summary
Top LGVN Correlated Resources
LGVN
Top 10 Correlated ETFs
LGVN
Top 10 Correlated Stocks
LGVN
In the News
LGVN Financial details
Company Rating
-
Market Cap
4.25M
Income
-22.14M
Revenue
709K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
23
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-1.34
Forward P/E
-
PEG
-1.51
P/S
41.25
P/B
4.02
P/C
-
P/FCF
-1.77
Quick Ratio
1.19
Current Ratio
1.49
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-10.19
EPS next Y
-
EPS next Q
-
EPS this Y
5.24%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
44.38%
Revenue last 5Y
-33.95%
Revenue Q/Q
-58%
EPS Q/Q
-8.6%
-
-
-
-
SMA20
-17.92%
SMA50
-8.39%
SMA100
-28.64%
Inst Own
-
Inst Trans
-
ROA
-171%
ROE
-145%
ROC
-2.53%
Gross Margin
22%
Oper. Margin
-2716%
Profit Margin
-2593%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.62-44.0
52W High
-96.55%
52W Low
+52%
RSI
50.79
Rel Volume
0.07
Avg Volume
941.58K
Volume
70.02K
Perf Week
10.95%
Perf Month
0.66%
Perf Quarter
-26.57%
Perf Half Y
-27.27%
-
-
-
-
Beta
0.196
-
-
Volatility
0.05%, 0.16%
Prev Close
4.11%
Price
1.52
Change
6.29%
Company Profile
- Volume Average 941.58K
- Market Capitalization 4.25M
- Employee 23
- CEO Mr. Mohamed Wa'el Ahmed Hashad
- Headquarters Miami,FL,US
- IPO Date 2021-02-12
-
Website
https://www.longeveron.com 
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
